More controversies...

Article

The World Congress on Controversies In Ophthalmology (COPHy) will take place in Barcelona, Spain, from 3?6 March 2011, following the first event held in the Czech Republic in March this year.

The World Congress on Controversies In Ophthalmology (COPHy) will take place in Barcelona, Spain, from 3–6 March 2011, following the first event held in the Czech Republic in March this year.

E posters from COPHY 2010 can be found here and include topics such as:

Optical Coherence Tomography Characteristics In Idiopathic Intracranial Hypertension

Conjunctival Lymphoma Masquerading A Chalzion In A Child

Lifestyle And Glaucoma

How can we preserve the visual function in idiopathic intracranial hypertension?

Regular, high and moderate intake of vegetables rich in antioxidants may reduce cataract risk in Central African diabetics

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.